Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  857 results for ""OMALIZUMAB""

Your Filters

Subject : anti-allergic agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Anaphylaxis* ; Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/therapeutic use

  • Source: Italian journal of pediatrics [Ital J Pediatr] 2024 Nov 09; Vol. 50 (1), pp. 232. Date of Electronic Publication: 2024 Nov 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101510759 Publication Model: Electronic Cited Medium: Internet ISSN: 1824-7288

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study.

  • Authors : Vickery BP; Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga; Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Ga. Electronic address: .

Subjects: Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/therapeutic use ; Desensitization, Immunologic*/Desensitization, Immunologic*/Desensitization, Immunologic*/methods ; Food Hypersensitivity*/Food Hypersensitivity*/Food Hypersensitivity*/drug therapy

  • Source: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Nov; Vol. 12 (11), pp. 2947-2954. Date of Electronic Publication: 2024 Sep 16.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Solar Urticaria and Omalizumab: A Retrospective Case-Control Study and Follow-Up.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/adverse effects ; Urticaria*/Urticaria*/Urticaria*/drug therapy

  • Source: Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2024 Oct; Vol. 115 (9), pp. T931-T932. Date of Electronic Publication: 2024 Jun 24.Publisher: Elsevier España Country of Publication: Spain NLM ID: 0373062 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study.

  • Authors : Pierrard G; CHU Lille, University Lille, Service de Dermatologie, Lille, France.; Bernier C

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Chronic Urticaria*/Chronic Urticaria*/Chronic Urticaria*/drug therapy

  • Source: Allergy [Allergy] 2024 Sep; Vol. 79 (9), pp. 2448-2457. Date of Electronic Publication: 2024 Jul 26.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Time-course and dose-effect of omalizumab in treating chronic idiopathic urticaria/chronic spontaneous urticaria.

  • Authors : Zhao A; School of Mathematics and Computing Science, Guangxi Colleges and Universities Key Laboratory of Data Analysis and Computation, Guilin University of Electronic Technology, Guilin, 541004, China.; Center for Applied Mathematics of Guangxi (GUET), Guilin, 541004, China.

Subjects: Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/administration & dosage ; Chronic Urticaria*/Chronic Urticaria*/Chronic Urticaria*/drug therapy ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Oct; Vol. 80 (10), pp. 1461-1469. Date of Electronic Publication: 2024 Jul 05.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
Periodical

The use of omalizumab in food allergy.

  • Authors : Alkotob S; Department of Pediatrics, Section of Immunology Allergy and Retrovirology, Texas Children's Hospital, Houston, Texas, USA.; Section of Allergy Immunology & Retrovirology, Baylor College of Medicine, Houston, Texas, USA.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Food Hypersensitivity*/Food Hypersensitivity*/Food Hypersensitivity*/drug therapy ; Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/therapeutic use

  • Source: Allergy [Allergy] 2024 Oct; Vol. 79 (10), pp. 2888-2889. Date of Electronic Publication: 2024 Apr 27.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

In chronic spontaneous urticaria, increased Galectin-9 expression on basophils and eosinophils is linked to high disease activity, endotype-specific markers, and response to omalizumab treatment.

  • Authors : Ji J; Department of Dermatology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Department of Dermatology, The Second Affiliated Hospital of Soochow University, Su Zhou, China.

Subjects: Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/therapeutic use ; Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/pharmacology ; Basophils*/Basophils*/Basophils*/metabolism

  • Source: Allergy [Allergy] 2024 Sep; Vol. 79 (9), pp. 2435-2447. Date of Electronic Publication: 2024 Jul 18.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens.

  • Authors : Kucharczyk A; Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.; Marczyk K

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Chronic Urticaria*/Chronic Urticaria*/Chronic Urticaria*/drug therapy ; Chronic Urticaria*/Chronic Urticaria*/Chronic Urticaria*/diagnosis

  • Source: Allergy [Allergy] 2024 Sep; Vol. 79 (9), pp. 2554-2557. Date of Electronic Publication: 2024 Jun 24.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Cost-Effectiveness of Omalizumab for Treatment of Food Allergy.

  • Authors : Shaker M; Section of Allergy and Clinical Immunology, Dartmouth Hitchcock Medical Center, Lebanon, NH; Depatments of Pediatrics and Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH. Electronic address: .

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/economics ; Cost-Benefit Analysis*

  • Source: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Sep; Vol. 12 (9), pp. 2481-2489.e1. Date of Electronic Publication: 2024 Jun 25.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Successful desensitisation to paclitaxel with omalizumab.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Oct 25; Vol. 31 (6), pp. 592-594. Date of Electronic Publication: 2024 Oct 25.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  857 results for ""OMALIZUMAB""